Imcyse continues patient enrolment in its Phase 1b trial in type 1 diabetes

Imcyse continues patient enrolment in its Phase 1b trial in type 1 diabetes

Liège, Belgium, November 14, 2017 – Imcyse, a biotechnology company developing active specific therapies for the treatment of severe chronic…